Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 1186

1.

Resveratrol promotes apoptosis through the induction of dual specificity phosphatase 1 and sensitizes prostate cancer cells to cisplatin.

Martínez-Martínez D, Soto A, Gil-Araujo B, Gallego B, Chiloeches A, Lasa M.

Food Chem Toxicol. 2018 Dec 12. pii: S0278-6915(18)30887-1. doi: 10.1016/j.fct.2018.12.014. [Epub ahead of print]

PMID:
30552915
2.

Piceatannol pretreatment alleviates acute cardiac injury via regulating PI3K-Akt-eNOS signaling in H9c2 cells.

Wang D, Zhang Y, Zhang C, Gao L, Li J.

Biomed Pharmacother. 2019 Jan;109:886-891. doi: 10.1016/j.biopha.2018.10.120. Epub 2018 Nov 5.

PMID:
30551542
3.

Resveratrol: from enhanced biosynthesis and bioavailability to multitargeting chronic diseases.

Pannu N, Bhatnagar A.

Biomed Pharmacother. 2019 Jan;109:2237-2251. doi: 10.1016/j.biopha.2018.11.075. Epub 2018 Nov 28. Review.

PMID:
30551481
4.

Resveratrol inhibits the growth of tumor cells under chronic stress via the ADRB‑2‑HIF‑1α axis.

Ma J, Xue M, Zhang S, Cheng L, Qian W, Duan W, Shen X.

Oncol Rep. 2018 Nov 28. doi: 10.3892/or.2018.6894. [Epub ahead of print]

PMID:
30535465
5.
6.

The direct and indirect inhibition effects of resveratrol against Toxoplasma gondii tachyzoites in vitro.

Chen QW, Dong K, Qin HX, Yang YK, He JL, Li J, Zheng ZW, Chen DL, Chen JP.

Antimicrob Agents Chemother. 2018 Dec 10. pii: AAC.01233-18. doi: 10.1128/AAC.01233-18. [Epub ahead of print]

PMID:
30530601
7.

DHS (trans-4,4'-dihydroxystilbene) suppresses DNA replication and tumor growth by inhibiting RRM2 (ribonucleotide reductase regulatory subunit M2).

Chen CW, Li Y, Hu S, Zhou W, Meng Y, Li Z, Zhang Y, Sun J, Bo Z, DePamphilis ML, Yen Y, Han Z, Zhu W.

Oncogene. 2018 Dec 5. doi: 10.1038/s41388-018-0584-6. [Epub ahead of print]

PMID:
30518875
8.

Resveratrol analog, N-(4-methoxyphenyl)-3,5-dimethoxybenzamide induces G2/M phase cell cycle arrest and apoptosis in HeLa human cervical cancer cells.

Lee KW, Chung KS, Lee JH, Choi JH, Choi SY, Kim S, Lee JY, Lee KT.

Food Chem Toxicol. 2018 Nov 30;124:101-111. doi: 10.1016/j.fct.2018.11.062. [Epub ahead of print]

PMID:
30508562
9.

Resveratrol, an activator of SIRT1, induces protective autophagy in non-small-cell lung cancer via inhibiting Akt/mTOR and activating p38-MAPK.

Wang J, Li J, Cao N, Li Z, Han J, Li L.

Onco Targets Ther. 2018 Nov 2;11:7777-7786. doi: 10.2147/OTT.S159095. eCollection 2018.

10.

Effect of autophagy on the resveratrol-induced apoptosis of ovarian cancer SKOV3 cells.

Wang H, Peng Y, Wang J, Gu A, Li Q, Mao D, Guo L.

J Cell Biochem. 2018 Nov 18. doi: 10.1002/jcb.28053. [Epub ahead of print]

PMID:
30450764
11.

Probing the mechanism of SIRT1 activation by a 1,4-dihydropyridine.

Manna D, Bhuyan R, Ghosh R.

J Mol Model. 2018 Nov 17;24(12):340. doi: 10.1007/s00894-018-3877-3.

PMID:
30448921
12.

Resveratrol suppresses colon cancer growth by targeting the AKT/STAT3 signaling pathway.

Li D, Wang G, Jin G, Yao K, Zhao Z, Bie L, Guo Y, Li N, Deng W, Chen X, Chen B, Liu Y, Luo S, Guo Z.

Int J Mol Med. 2019 Jan;43(1):630-640. doi: 10.3892/ijmm.2018.3969. Epub 2018 Nov 1.

PMID:
30387805
13.

Novel Combination of Arsenic Trioxide (As2O3) Plus Resveratrol in Inducing Programmed Cell Death of Human Neuroblastoma SK-N-SH Cells.

Yen CM, Tsai CW, Chang WS, Yang YC, Hung YW, Lee HT, Shen CC, Sheu ML, Wang JY, Gong CL, Cheng WY, Bau DT.

Cancer Genomics Proteomics. 2018 Nov-Dec;15(6):453-460. doi: 10.21873/cgp.20104.

PMID:
30343279
14.

Resveratrol enhances the chemotherapeutic response and reverses the stemness induced by gemcitabine in pancreatic cancer cells via targeting SREBP1.

Zhou C, Qian W, Ma J, Cheng L, Jiang Z, Yan B, Li J, Duan W, Sun L, Cao J, Wang F, Wu E, Wu Z, Ma Q, Li X.

Cell Prolif. 2018 Oct 19:e12514. doi: 10.1111/cpr.12514. [Epub ahead of print]

PMID:
30341797
15.

Resveratrol restores sensitivity of glioma cells to temozolamide through inhibiting the activation of Wnt signaling pathway.

Yang HC, Wang JY, Bu XY, Yang B, Wang BQ, Hu S, Yan ZY, Gao YS, Han SY, Qu MQ.

J Cell Physiol. 2018 Oct 14. doi: 10.1002/jcp.27409. [Epub ahead of print]

PMID:
30317578
16.

Endocrine therapy-resistant breast cancer model cells are inhibited by soybean glyceollin I through Eleanor non-coding RNA.

Yamamoto T, Sakamoto C, Tachiwana H, Kumabe M, Matsui T, Yamashita T, Shinagawa M, Ochiai K, Saitoh N, Nakao M.

Sci Rep. 2018 Oct 12;8(1):15202. doi: 10.1038/s41598-018-33227-y.

17.

Molecular Responses of Cancers by Natural Products: Modifications of Autophagy Revealed by Literature Analysis.

Yeung AWK, El-Demerdash A, Berindan-Neagoe I, Atanasov AG, Ho YS.

Crit Rev Oncog. 2018;23(5-6):347-370. doi: 10.1615/CritRevOncog.2018027566.

PMID:
30311565
18.

Combination of resveratrol and 5-flurouracil enhanced anti-telomerase activity and apoptosis by inhibiting STAT3 and Akt signaling pathways in human colorectal cancer cells.

Chung SS, Dutta P, Austin D, Wang P, Awad A, Vadgama JV.

Oncotarget. 2018 Aug 31;9(68):32943-32957. doi: 10.18632/oncotarget.25993. eCollection 2018 Aug 31.

19.

Intranasal administration of resveratrol successfully prevents lung cancer in A/J mice.

Monteillier A, Voisin A, Furrer P, Allémann E, Cuendet M.

Sci Rep. 2018 Sep 24;8(1):14257. doi: 10.1038/s41598-018-32423-0.

20.

Development of Hot Melt Extruded Solid Dispersion of Tamoxifen Citrate and Resveratrol for Synergistic Effects on Breast Cancer Cells.

Chowdhury N, Vhora I, Patel K, Bagde A, Kutlehria S, Singh M.

AAPS PharmSciTech. 2018 Sep 14. doi: 10.1208/s12249-018-1111-3. [Epub ahead of print]

PMID:
30218267

Supplemental Content

Loading ...
Support Center